CencoraWBO:ABC -0.27%69 Days Payable is 65.44 as of Mar. 2026, which is 7% above its 10-year median of 61.02. GuruFocus rates WBO:ABC with a GF Score™ of 69/100 and a GF Value™ of €259.45 (Fairly Valued). The stock has 1 warning sign investors should review. Among 117 Medical Distribution companies, Cencora ranks worse than 63.25% on this metric.
Cencora's average Accounts Payable for the
three
months ended in Mar. 2026 was €46,378 Mil. Cencora's Cost of Goods Sold for the
three
months ended in Mar. 2026 was €64,674 Mil.
Hence, Cencora's Days Payable for the
three
months ended in Mar. 2026 was 65.44.
The historical rank and industry rank for Cencora's Days Payable or its related term are showing as below:
WBO:ABC'
s Days Payable Range Over the Past 10 Years
Min: 57.36 Med: 61.02 Max: 62.23
Current: 60.92
During the past 13 years, Cencora's highest Days Payable was 62.23. The lowest was 57.36. And the median was 61.02.
WBO:ABC's Days Payable is ranked worse than 63.25% of 117
companies
in the Medical Distribution industry
Industry Median: 79.11
vs WBO:ABC: 60.92
Cencora's Days Payable
increased
from Mar. 2025 (64.06) to Mar. 2026 (65.44).
It may suggest that Cencoradelayed paying its suppliers.
Cencora Days Payable Related Terms
Cencora Days Payable Historical Data
* Premium members only.
The historical data trend for Cencora's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:ABC vs CAH, MCK, HSIC: Days Payable Comparison
For the Medical Distribution subindustry, Cencora's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cencora Days Payable vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cencora's Days Payable distribution charts can be found below:
* The bar in red indicates where Cencora's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Cencora's Days Payable for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cencora (WBO:ABC) has a Days Payable of 65.44 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cencora and its competitors. This is near median its historical median of 61.02. Over the past decade, Cencora's Days Payable has ranged from 57.36 to 62.23. According to the industry distribution chart, Cencora ranks #74 out of 117 companies in the Medical Distribution industry, placing it in the top 63.2%.
Is Cencora's Days Payable too high?
Cencora's current Days Payable of 65.44 is near median its 10-year median of 61.02. Over the past 10 years, this metric has ranged from a low of 57.36 to a high of 62.23. The Medical Distribution industry median Days Payable is 79.11. Cencora's value of 65.44 is 17.3% below this industry median. Based on the distribution chart, Cencora ranks #74 out of 117 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Cencora has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cencora's Days Payable compare to CAH and MCK?
According to the Medical Distribution industry distribution chart, Cencora ranks #74 out of 117 companies for Days Payable. This places Cencora in the lower half of its industry. The industry median Days Payable is 79.11. Cencora's value of 65.44 is 17.3% below this benchmark. Historically, Cencora's own Days Payable has ranged from 57.36 to 62.23 over the past decade. While the company's 10-year median is 61.02 vs. the industry median of 79.11, Cencora has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Distribution company?
The median Days Payable among Medical Distribution companies is 79.11, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cencora's current Days Payable of 65.44 is 17.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cencora and its competitors. For the Medical Distribution industry, the median Days Payable is 79.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cencora's current Days Payable is 65.44, which is near median its own 10-year median of 61.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cencora stock overvalued right now?
Based on GuruFocus' analysis, Cencora (WBO:ABC) is currently considered Fairly Valued. The stock's GF Value™ is €259.45, compared to a current price of €254.30 — trading 2% below its estimated fair value. The current Days Payable is 65.44, which is near median its 10-year median of 61.02 and 17.3% below the Medical Distribution industry median of 79.11. Cencora's overall GF Score™ is 69/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Cencora (WBO:ABC), the current Days Payable is 65.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cencora (WBO:ABC) Overvalued in 2026?
Based on GuruFocus' analysis, Cencora stock appears to be undervalued.
The current stock price of €254.30 is trading 2% below its estimated GF Value™ of €259.45.
GuruFocus considers Cencora to be Fairly Valued.
Key valuation signals for WBO:ABC:
Days Payable: 65.44 (near median its 10-year median of 61.02)
GF Value™: €259.45 vs. price of €254.30 (2% below fair value)
Industry Position: 17.3% below the Medical Distribution median (#74 of 117)
No single metric tells the full story. See the WBO:ABC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
69GF Score
Get the complete analysis for WBO:ABC
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:ABC has been successfully added to your 
